Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
43.36
+1.16 (2.75%)
At close: Nov 26, 2025, 4:00 PM EST
43.98
+0.62 (1.43%)
After-hours: Nov 26, 2025, 7:08 PM EST
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $3.43 billion as of November 26, 2025. Its market cap has increased by 362.52% in one year.
Market Cap
3.43B
Enterprise Value
2.84B
1-Year Change
362.52%
Ranking
Category
Stock Price
$43.36
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $3.43B, an increase of 449.12%. That is a compound annual growth rate of 83.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 3.43B | 460.11% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
| Feb 10, 2023 | 624.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |